Skip to main content

Peer Review reports

From: IGF-1R down regulates the sensitivity of hepatocellular carcinoma to sorafenib through the PI3K / akt and RAS / raf / ERK signaling pathways

Original Submission
7 Apr 2022 Submitted Original manuscript
9 May 2022 Reviewed Reviewer Report
16 Jun 2022 Reviewed Reviewer Report
25 Sep 2022 Author responded Author comments - Xiaolong Tang
Resubmission - Version 2
25 Sep 2022 Submitted Manuscript version 2
10 Oct 2022 Author responded Author comments - Xiaolong Tang
Resubmission - Version 3
10 Oct 2022 Submitted Manuscript version 3
1 Nov 2022 Author responded Author comments - Xiaolong Tang
Resubmission - Version 4
1 Nov 2022 Submitted Manuscript version 4
24 Nov 2022 Reviewed Reviewer Report
30 Nov 2022 Reviewed Reviewer Report
3 Jan 2023 Author responded Author comments - Xiaolong Tang
Resubmission - Version 5
3 Jan 2023 Submitted Manuscript version 5
14 Jan 2023 Reviewed Reviewer Report
17 Jan 2023 Reviewed Reviewer Report
Resubmission - Version 6
Submitted Manuscript version 6
Publishing
18 Jan 2023 Editorially accepted
25 Jan 2023 Article published 10.1186/s12885-023-10561-7

You can find further information about peer review here.

Back to article page